Company News: Page (1) of 1 - 05/18/17 Email this story to a friend. email article Print this page (Article printing at page facebook

Karuna Pharmaceuticals to Present KarXT Tolerability Proof-of-Concept Data for KarXT, A Novel Antipsychotic Agent Targeting the Muscarinic Receptors, at Two Upcoming Medical Meetings

(May 18, 2017)
This article is no longer available,but here are some related topics.

Page: 1

Related Keywords:


Our Privacy Policy --- @ Copyright, 2015 Digital Media Online, All Rights Reserved